Webinar To Assist Applicants for Grants To Study Specific Cannabis ComponentsFebruary 14, 2019 David Shurtleff, Ph.D. Identifying and developing novel strategies to treat acute and chronic pain are strong public health needs. More than 25 million adults in the U.S. experience daily pain. And, more than 2 million Americans have an opioid use disorder (OUD). The National Institutes of Health urges the scientific community to help develop solutions to these public health emergencies. According to a growing body of literature, the cannabis plant may have analgesic properties. However, the progress of research into those potential properties has been slow. More knowledge is needed regarding the basic biological activity of the plant’s diverse phytochemicals—especially, its minor cannabinoids and terpenes, few of which have been extensively studied— to be able to tackle many scientific questions. These questions may include: Can the analgesic constituents of cannabis be isolated and separated from its psychoactive constituents? What are the targets and mechanisms of action for these molecules? Could these constituents be further developed to treat pain, OUD, and other related conditions (e.g., sleep disturbance)? If you’re a researcher who is interested in applying for an NCCIH grant in this area, please join us for a preapplication Technical Assistance Webinar on Minor Cannabinoids and Pain on Thursday, February 21, 2019, from 3 p.m. to 4 p.m. ET. |
.png)
No hay comentarios:
Publicar un comentario